Chandan Healthcare Limited IPO

Chandan Healthcare Ltd

₹1,20,800 /800 sharesMinimum Investment

Chandan Healthcare Limited IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
10 Feb ‘25 - 12 Feb ‘25₹1,20,800800₹151 - ₹159
Issue SizeIPO Doc
107.36Cr
RHP PDF

Subscription rate

As of 12 Feb'25, 05:00 PM
Qualified Institutional Buyers4.15x
Non-Institutional Investor17.13x
Retail Individual Investor1.77x
Employees0.16x
Total5.06x

About Chandan Healthcare Limited

Chandan Healthcare is a diagnostic services provider. The company offers pathology and radiology testing, along with medical consultation services. The company's test portfolio includes routine and specialised pathology tests, as well as imaging services like X-rays, ultrasounds, CT scans, and MRIs. Chandan Healthcare operates over 300 sample collection centres, seven central reference laboratories, and 26 satellite laboratories across tier-2 cities and towns in Uttar Pradesh, Uttarakhand, and Rajasthan. It follows a cluster and collection points model, where samples are gathered from designated locations and transported to central laboratories for testing.;
Founded in
2003
Managing director
Mr Amar Singh
Parent organisation
Chandan Healthcare Ltd

Strengths & Financials of Chandan Healthcare Limited

Strengths
Risks
Chandan Healthcare operates a diagnostic network across North India, with one flagship laboratory, seven central laboratories, 26 satellite centres, and over 300 sample collection centres. As of August 31, 2024, the company’s presence spans more than 15 cities and towns in Uttar Pradesh and over 10 in Uttarakhand.
The company claims to have a diverse test portfolio, offering 1,118 tests, including 169 routine pathology tests, 713 specialised pathology tests, and 236 radiology tests. Its radiology facilities reportedly include 11 CT scanners and four MRI machines.
Chandan Healthcare expands its reach in remote areas by following a cluster and collection points model, where samples from nearby areas are gathered and transported to central laboratories for testing.
The company has eight NABL-accredited laboratories and three of its diagnostic centres are NABH-accredited.
In FY24, Chandan Healthcare claims to have conducted approximately 61.77 lakh tests for 15.64 lakh patients.
The company has seen a consistent increase in revenue from operations. Revenue from operations increased from Rs 119.56 crore in FY22 to Rs 136.89 crore in FY23 to Rs 176.59 crore in FY24.

Chandan Healthcare Limited Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Chandan Healthcare Limited IPO

Apply asPrice bandApply upto
Regular151 - 159₹2 Lakh
Employee136 - 144₹2 Lakh
High Networth Individual151 - 159₹2 - 5 Lakh
For Chandan Healthcare Limited IPO, eligible investors can apply as Regular & Employee.
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.7.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW